治疗药物管理：它会是耐多药结核病治疗的未来吗？ - Suppr

Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?

作者信息

Srivastava Shashikant, Peloquin Charles A, Sotgiu Giovanni, Migliori Giovanni Battista

机构信息

UT Southwestern Medical Center, Dallas, TX.

出版信息

Eur Respir J. 2013 Dec;42(6):1449-53. doi: 10.1183/09031936.00073213.

DOI:10.1183/09031936.00073213

PMID:24293417

Abstract

摘要

相似文献

Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?

Eur Respir J. 2013 Dec;42(6):1449-53. doi: 10.1183/09031936.00073213.

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.

Eur Respir J. 2013 Dec;42(6):1614-21. doi: 10.1183/09031936.00001913. Epub 2013 Mar 21.

Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis.

Antimicrob Agents Chemother. 2013 Aug;57(8):3676-80. doi: 10.1128/AAC.00558-13. Epub 2013 May 20.

Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.

Clin Pharmacokinet. 2010 Aug;49(8):559-65. doi: 10.2165/11532080-000000000-00000.

Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

Antimicrob Agents Chemother. 2012 Nov;56(11):5758-63. doi: 10.1128/AAC.01054-12. Epub 2012 Aug 27.

Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

Ther Drug Monit. 2010 Feb;32(1):97-101. doi: 10.1097/FTD.0b013e3181cc6d6f.

Linezolid for multidrug-resistant tuberculosis: How should we approach it?

Enferm Infecc Microbiol Clin. 2016 Feb;34(2):83-4. doi: 10.1016/j.eimc.2015.12.002. Epub 2016 Jan 12.

Linezolid for multidrug-resistant tuberculosis.

Lancet Infect Dis. 2012 Jul;12(7):502-3. doi: 10.1016/S1473-3099(12)70137-8.

Comment on: daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.

J Antimicrob Chemother. 2012 Aug;67(8):2055-6; author reply 2056-7. doi: 10.1093/jac/dks154. Epub 2012 Apr 27.

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8.

引用本文的文献

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis.

Antimicrob Agents Chemother. 2025 Feb 13;69(2):e0108424. doi: 10.1128/aac.01084-24. Epub 2025 Jan 16.

Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis.

Infect Drug Resist. 2022 Nov 28;15:6839-6852. doi: 10.2147/IDR.S389442. eCollection 2022.

Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00384-19. Print 2019 Jul.

Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). doi: 10.1128/AAC.01092-18. Print 2018 Dec.

Association of serum leptin levels and pulmonary tuberculosis: a meta-analysis.

J Thorac Dis. 2018 Feb;10(2):1027-1036. doi: 10.21037/jtd.2018.01.70.

Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.

J Thorac Dis. 2016 Oct;8(10):2666-2671. doi: 10.21037/jtd.2016.10.14.

Recent developments in the diagnosis and management of tuberculosis.

NPJ Prim Care Respir Med. 2016 Nov 3;26:16078. doi: 10.1038/npjpcrm.2016.78.

New anti-tuberculosis drugs and regimens: 2015 update.

ERJ Open Res. 2015 May 6;1(1). doi: 10.1183/23120541.00010-2015. eCollection 2015 May.

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.

Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.

Int J Tuberc Lung Dis. 2016 Jun;20(6):844-7. doi: 10.5588/ijtld.15.0882.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献